A recent study on AML cells has confirmed that the inhibition of EZH2 to de-condense the chromatin could enhance the chemotherapeutic accessibility to chromatin, chemotherapy-induced DNA damage, and cell apoptosis [50]. The gene discussed is EZH2; the disease is acute myeloid leukemia.